Sera PROGNOSTICS, Inc. (SERA) intrinsic value & 10-year financials

Sera PROGNOSTICS, Inc. (SERA) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue grew 26.5% a year to $81.0K, with an average return on invested capital of -58.2%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$2.06
Market cap
$98.2M
Revenue (FY2025)
$81.0K
Revenue growth (7-yr CAGR)
26.5%
ROIC (10-yr avg)
-58.2%
Free cash flow (FY2025)
-$26.3M

SERA 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $81.0K -$31.9M -$0.67 -$26.3M -45066.7% -62.1%
FY2024 $77.0K -$32.9M -$0.99 -$14.2M -47577.9% -66.1%
FY2023 $306.0K -$36.2M -$1.16 -$27.3M -13013.4% -57.7%
FY2022 $268.0K -$44.2M -$1.43 -$35.4M -17034.3% -60.6%
FY2021 $82.0K -$35.0M -$1.17 -$32.9M -43164.6% -44.4%
FY2020 $25.0K -$19.8M -$0.64 -$17.0M -71884.0% —
FY2019 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

SERA PROGNOSTICS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

SERA PROGNOSTICS, INC. has historically struggled to out-earn its cost of capital, averaging just -58.2% ROIC.

SERA PROGNOSTICS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, SERA PROGNOSTICS, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-22.25 per share.

SERA stock: frequently asked questions

What is the intrinsic value of Sera PROGNOSTICS, Inc. (SERA) stock?

Graham's formula only works with positive earnings. Sera PROGNOSTICS, Inc. reported diluted EPS of -$0.67 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Sera PROGNOSTICS, Inc. generate free cash flow?

Sera PROGNOSTICS, Inc. generated -$26.3M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 6 reported years.

What is SERA's return on invested capital?

Average ROIC over the last 7 fiscal years was -58.2%, and average return on equity was -118.2%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SERA data come from?

From Sera PROGNOSTICS, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 12, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medical laboratories stocks